Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate: Summer Studentship Award - Institute Community Support

Université Laval

$5,000.00

The characterization of the MICL inhibitory pathway in MSU-induced inflammation: implications for gout

FY 2016-17

Summary
Chronic inflammatory diseases are characterized by an imbalance in the production of molecules that regulate the immune response favouring those with pro-inflammatory properties. Most drugs used to treat these diseases target pro-inflammatory molecules to block their activity. Although these drugs are effective, they cause undesirable side effects. A more recent therapeutic approach that has proven to be successful in treating certain diseases involves targeting molecules that our body normally uses to dampen the immune response. The long-term goal of our research is to develop drugs that stimulate these natural inhibitory molecules to dampen inflammation. Prior to developing such therapies, we have to identify the inhibitory molecules relevant to chronic inflammatory diseases. We have identified one such protein known as the myeloid inhibitory C-type lectin-like receptor (MICL). We have shown that MICL is involved in gout and rheumatoid arthritis. MICL negatively regulates the activation of the blood cell known as the neutrophil. Neutrophils play a key role during the symptomatic phase of gout during which they accumulate in large numbers in affected joints where they cause inflammation and damage. The objective of this project is to gain insight into how MICL is able to dampen the activation of the neutrophil and complete our search for all the neutrophil functions that MICL regulates. The results of this research will provide a better understanding of how this negative regulator works and how it contributes to the pathogenesis of gout. Moreover, it will form the basis of future studies that will focus on targeting the MICL pathway to treat gout and potentially other types of arthritis.
Program
Undergraduate: Summer Studentship Award - Institute Community Support
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
364454
Name
Shen Yunyun (Anna)
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Summer Studentships in Musculoskeletal Health
Projecttitle
The characterization of the MICL inhibitory pathway in MSU-induced inflammation: implications for gout
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Summer Studentship Award - Institute Community Support
Keyworddelim
Arthritis; Cell Biology; Gout; Inhibitory Receptors; Micl; Neutrophil; Signalling
Abstract
Chronic inflammatory diseases are characterized by an imbalance in the production of molecules that regulate the immune response favouring those with pro-inflammatory properties. Most drugs used to treat these diseases target pro-inflammatory molecules to block their activity. Although these drugs are effective, they cause undesirable side effects. A more recent therapeutic approach that has proven to be successful in treating certain diseases involves targeting molecules that our body normally uses to dampen the immune response. The long-term goal of our research is to develop drugs that stimulate these natural inhibitory molecules to dampen inflammation. Prior to developing such therapies, we have to identify the inhibitory molecules relevant to chronic inflammatory diseases. We have identified one such protein known as the myeloid inhibitory C-type lectin-like receptor (MICL). We have shown that MICL is involved in gout and rheumatoid arthritis. MICL negatively regulates the activation of the blood cell known as the neutrophil. Neutrophils play a key role during the symptomatic phase of gout during which they accumulate in large numbers in affected joints where they cause inflammation and damage. The objective of this project is to gain insight into how MICL is able to dampen the activation of the neutrophil and complete our search for all the neutrophil functions that MICL regulates. The results of this research will provide a better understanding of how this negative regulator works and how it contributes to the pathogenesis of gout. Moreover, it will form the basis of future studies that will focus on targeting the MICL pathway to treat gout and potentially other types of arthritis.
Competitiondate
201701
Approvedterm2
0 yr 4 mths
Pinamesdelim
Shen, Yunyun (Anna)
Approvedterm
0 an 4 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $5,000~ $0~
Université Laval - $5,000 Grant (2016-17) | Canada Spends